Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the ground transportation stocks, including Heartland Express (NASDAQ:HTLD) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst performers in the surgical equipment & consumables - diversified industry.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers.
Let’s dig into the relative performance of MGP Ingredients (NASDAQ:MGPI) and its peers as we unravel the now-completed Q4 beverages, alcohol, and tobacco earnings season.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSE:MOH) and its peers.
Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the professional tools and equipment industry, including Lincoln Electric (NASDAQ:LECO) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the travel and vacation providers industry, including Marriott (NASDAQ:MAR) and its peers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Procore (NYSE:PCOR) and the rest of the design software stocks fared in Q4.